CYTOMEGALOVIRUS INFECTION
Clinical trials for CYTOMEGALOVIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTION trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA vaccine aims to shield transplant patients from dangerous virus
⭐️ VACCINE ⭐️ Recruiting nowThis study tests an mRNA vaccine (mRNA-1647) to prevent cytomegalovirus (CMV) infection in people who have had a stem cell transplant. About 224 participants will receive either the vaccine or a placebo. The goal is to see if the vaccine can safely prevent serious CMV infections …
Matched conditions: CYTOMEGALOVIRUS INFECTION
Phase: PHASE2 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:41 UTC
-
New drug combo aims to knock out CMV faster in kidney transplant patients
Disease control Recruiting nowThis study tests whether adding letermovir to standard valganciclovir treatment works better than valganciclovir alone for cytomegalovirus (CMV) infections in kidney transplant recipients. About 80 adult participants will receive either the combination or the single drug, and res…
Matched conditions: CYTOMEGALOVIRUS INFECTION
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New study to reveal hidden costs of common virus in young transplant patients
Knowledge-focused Recruiting nowThis study looks back at medical records of 230 children in Italy who had a stem cell transplant. The goal is to understand how often a common virus called CMV causes problems and what those problems cost. The findings will help doctors and hospitals better manage care for these …
Matched conditions: CYTOMEGALOVIRUS INFECTION
Sponsor: MSD Italia S.r.l. • Aim: Knowledge-focused
Last updated May 11, 2026 20:40 UTC